Suspension trapping and data-independent acquisition enable high-flow liquid chromatography-tandem mass spectrometry-based amyloidosis typing in clinical laboratories
Mann, Morgan W., Chen, Fangjun, Zhu, Chunfang, Lu, Chenyin, Liang, Brooke, Kambham, Neeraja, Troxell, Megan L., Luo, Ruben Y. Clinical Proteomics
· Springer Nature
· 2026-09-03
· DOI: 10.1186/s12014-026-09628-x
Abstract
Background Mass spectrometry enables highly specific and multiplexed typing of amyloid plaques, and is widely used for this purpose in clinical reference laboratories. However, this technique relies on nanoflow liquid chromatography (LC), which reduces penetrance of this methodology due to high up-front and operational costs associated with nanoflow. This study introduces a tandem mass spectrometry (MS/MS) method with high-flow LC, which shortens the sample preparation workflow to < $$\:8$$ hours. Methods Suspension trapping was utilized to process laser capture microdissected amyloid plaques from 47 patient samples (10 from heart, 37 from kidney). The samples were then evaluated by LC-MS/MS with data-independent acquisition (DIA). The employment of suspension trapping and DIA allow for the use of high-flow LC, which is most commonly coupled with MS in clinical laboratories. A custom selection heuristic was developed to identify the most likely amyloidogenic protein from each plaque. Results A novel high-flow LC-DIA-MS/MS method was able to identify the amyloidogenic protein in ~ 96% of plaques in both training ( n = 25) and testing ( n = 22) sets. All inaccuracies ( n = 2) were caused by poor identification of immunoglobulin lambda proteins in post-treatment biopsy specimens and in dual amyloid-type plaques. Conclusions Employing suspension trapping and DIA, a novel high-flow LC-DIA-MS/MS method was established for amyloidosis typing of LCM tissue sections, which shortens the sample preparation workflow to < 8 h, while simultaneously utilizing high-flow LC in the place of traditionally used nanoflow LC, enabling it to be used more widely in clinical laboratories.
Mann, Morgan W., Chen, Fangjun, Zhu, Chunfang et al. Suspension trapping and data-independent acquisition enable high-flow liquid chromatography-tandem mass spectrometry-based amyloidosis typing in clinical laboratories. // Clinical Proteomics. – 2026. – DOI: 10.1186/s12014-026-09628-x. – URL: https://doi.org/10.1186/s12014-026-09628-x
Mann, Morgan W, Chen, Fangjun, Zhu, Chunfang, Lu, Chenyin, Liang, Brooke, Kambham, Neeraja, Troxell, Megan L, Luo, & Ruben Y (2026). Suspension trapping and data-independent acquisition enable high-flow liquid chromatography-tandem mass spectrometry-based amyloidosis typing in clinical laboratories. Clinical Proteomics. https://doi.org/10.1186/s12014-026-09628-x
Mann, et al. “Suspension trapping and data-independent acquisition enable high-flow liquid chromatography-tandem mass spectrometry-based amyloidosis typing in clinical laboratories.” Clinical Proteomics, 2026. doi:10.1186/s12014-026-09628-x.
@article{Mann2026,
title = {Suspension trapping and data-independent acquisition enable high-flow liquid chromatography-tandem mass spectrometry-based amyloidosis typing in clinical laboratories},
author = {Mann and W., Morgan and Chen and Fangjun and Zhu and Chunfang and Lu and Chenyin and Liang and Brooke and Kambham and Neeraja and Troxell and L., Megan and Luo and Y., Ruben},
journal = {Clinical Proteomics},
year = {2026},
doi = {10.1186/s12014-026-09628-x},
url = {https://doi.org/10.1186/s12014-026-09628-x}
}
Background Prediabetes is a heterogeneous metabolic state that may progress to diabetes or revert to normal fasting glucose (NFG). This study evaluated the associations of seven non-traditional lipid-related indices with glucose state...
Background Osteosarcoma (OS), a rare and aggressive cancer of the bone, is typically diagnosed on the basis of extensive imaging and tissue biopsy. Currently, there are no biomarkers that can be used for diagnosis, early detection, or...
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common inherited kidney disorder and a leading monogenic cause of end-stage renal disease (ESRD), affecting up to 12 million people worldwide. The disease arises from...
Background Metabolic dysfunction and frailty are interrelated dimensions of cardiometabolic vulnerability. We examined four frailty-integrated lipid-related metabolic indices in relation to incident cardiovascular disease (CVD) and...
Lipid accumulation during liver regeneration has long been recognized, but its functional significance remains controversial. Transient regeneration-associated steatosis develops rapidly after partial hepatectomy or liver injury and may...